Access cutting-edge pulmonary arterial hypertension treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access pulmonary arterial hypertension specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary arterial hypertension treatment provided free
Randomized, triple-masked, parallel arm clinical trial of empagliflozin versus placebo in pulmonary arterial hypertension (PAH) participants on stable approved PAH-targeted medical therapy.
Sponsor: Gustavo A Heresi, MD, MS
Check if you qualify for this pulmonary arterial hypertension clinical trial in Baltimore, MD
If you're searching for pulmonary arterial hypertension treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary arterial hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.